A Harvard Global Health Institute Summit
Tuesday, February 26, 2019
LEAD PHOTO: © MATT HEDT
Blog
Posted on March 27, 2019
By Kathryn E. Horneffer | HGHI Research Assistant — “Who has heard of Gartner’s hype cycle?” Adam Landman addressed his audience, pointing to an image on the slides behind him. The IT research company Gartner had created the hype cycle concept to represent the typical process of adoption of technology into society. Most artificial … Continue reading→
Posted on March 3, 2019
By Alvin Powell | Harvard Staff Writer — In 2016, a Google team announced it had used artificial intelligence to diagnose diabetic retinopathy — one of the fastest-growing causes of blindness — as well as trained eye doctors could. In December 2018, Microsoft and the pharmaceutical giant Novartis announced a partnership to develop an AI-powered … Continue reading→
WHY THIS CONFERENCE?
Background
AI-driven applications for health care are booming globally. While much of the attention is being given to innovations from high-income contexts, there is a growing community of data scientists, entrepreneurs and healthcare workers who are exploring how AI can improve health outcomes. Indeed, innovative ideas, motivation and a deep understanding of the local needs are present in many countries – yet there is an urgent need for more opportunities to research and publish on AI in global health; to learn how to transition great ideas into impactful solutions; to connect across disciplines, sectors and geographies; and to build a repository of evidence and lessons learned that can serve as a best practice guide for those innovating in the space. In response to the potential as well as the need, the Harvard Global Health Institute and partners will convene experts, students, innovators, policymakers and others driving the health data science and AI agenda.
SPEAKERS
Multi-disciplinary, international, collaborative: Our speakers come from a wide range of academic disciplines, including law, clinical medicine and data science, as well as from multinational entities, philanthropic organizations and industry.